4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065103
President sold 45,000 shares at an average $62.47 ($2,810,983)
- President acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-12-21 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2020-12-21 | Sale | −7,677 | $59.15 | $454,095 | 7,323 | D |
| RUBINSTEIN JULIE President | 2020-12-21 | Sale | −7,323 | $59.72 | $437,330 | 0 | D |
| RUBINSTEIN JULIE President | 2020-12-22 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2020-12-22 | Sale | −13,100 | $63.62 | $833,422 | 1,900 | D |
| RUBINSTEIN JULIE President | 2020-12-22 | Sale | −1,900 | $64.36 | $122,284 | 0 | D |
| RUBINSTEIN JULIE President | 2020-12-23 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2020-12-23 | Sale | −8,465 | $63.90 | $540,914 | 6,535 | D |
| RUBINSTEIN JULIE President | 2020-12-23 | Sale | −5,506 | $64.59 | $355,633 | 1,029 | D |
| RUBINSTEIN JULIE President | 2020-12-23 | Sale | −1,029 | $65.41 | $67,307 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2020-12-21 | Option exercise · Stock Option (Right to Buy) | −15,000 | 485,000 | D | ||
| RUBINSTEIN JULIE President | 2020-12-22 | Option exercise · Stock Option (Right to Buy) | −15,000 | 470,000 | D | ||
| RUBINSTEIN JULIE President | 2020-12-23 | Option exercise · Stock Option (Right to Buy) | −15,000 | 455,000 | D | ||
| Open-market sales · 45,000 sh · avg $62.47 · $2,810,983 | |||||||
Loading xslF345X03/doc4.xml…